Update on Therapeutic Options in Lipodystrophy

Akinci B., Meral R., Oral E. A.

CURRENT DIABETES REPORTS, vol.18, no.12, 2018 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 18 Issue: 12
  • Publication Date: 2018
  • Doi Number: 10.1007/s11892-018-1100-7
  • Journal Name: CURRENT DIABETES REPORTS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Keywords: Generalized lipodystrophy, Investigational treatments, Leptin, Partial lipodystrophy, LEPTIN-REPLACEMENT THERAPY, FAMILIAL PARTIAL LIPODYSTROPHY, CONGENITAL GENERALIZED LIPODYSTROPHY, REVERSES INSULIN-RESISTANCE, BASE-LINE CHARACTERISTICS, HIGH-DENSITY-LIPOPROTEIN, GASTRIC BYPASS-SURGERY, APOLIPOPROTEIN C-III, LONG-TERM TREATMENT, GROWTH FACTOR-I
  • Istanbul University Affiliated: No

Abstract

Purpose of Review The purpose of this review is to summarize the therapeutic approach for lipodystrophy syndromes with conventional treatment options and metreleptin therapy in detail and to point out the current investigational treatments in development.